NFKB2 GeneD81.4

Last updated on: 05.07.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The NFKB2 gene (NFKB2-stands for Nuclear Factor Kappa B Subunit 2) is a protein-coding gene located on chromosome 10q24.32. There is a pseudogene for this gene on chromosome 18. Alternative splicing results in multiple transcript variants.

Clinical pictureThis section has been translated automatically.

Diseases associated with NFKB2 include immunodeficiency, common variable, 10(immunodeficiency 10 and NLKB2 defect; CVID10).

Chromosomal rearrangements and translocations of this locus have been observed in B-cell lymphomas.

Note(s)This section has been translated automatically.

NF-kappa-B complexes are maintained in an inactive state in the cytoplasm and are complexed with members of the NF-kappa-B inhibitor family (I-kappa-B). In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to various activators and subsequently degraded, releasing the active NF-kappa-B complex that migrates to the nucleus.

In a non-canonical activation pathway, the CHUK/IKKA homodimer activated by MAP3K14 phosphorylates NFKB2/p100 associated with RelB, triggering its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B-RelB-p52 complexes

LiteratureThis section has been translated automatically.

  1. Aird A et al (2019) Novel heterozygous mutation in NFKB2 is associated with early onset CVID and a functional defect in NK cells complicated by disseminated CMV infection and severe nephrotic syndrome. Front Pediat 7: 303.
  2. Brue T et al (2014) Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies. BMC Med Genet 15: 139.
  3. Chen K et al (2013) Germline mutations in NFKB2 implicate the noncanonical NF-kappa-B pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet 93: 812-824.
  4. Lee CE et al (2014) Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. Blood 124: 2964-2972.
  5. Liu Y et al (2014) Novel NFKB2 mutation in early-onset CVID J Clin Immun 34: 686-690.
  6. Quentien MH et al (2012) Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections. J Clin Endocr Metab 97: E121-E128.
  7. Tucker E et al (2007) A novel mutation in the Nfkb2 gene generates an NF-kappa-B2 'super repressor. J Immun 179: 7514-7522.

Last updated on: 05.07.2022